-
Posted by
Two Blokes April 23, 2025 -
Filed in
Stock
-
14 views
2025 First Quarter Sales Press release – Paris, April 23, 2025, at 7:30am CEST Strong start to the year, demonstrating the relevance of our health-oriented portfolio Strong Q1 2025, with sales of €6,844m, up +4.3% on a like-for-like (LFL) basis Contributions from both volume/mix (+1.9%) and price (+2.4%); positive volume/mix again in all categories Broad-based growth, demonstrating the resilience of our business Very strong performance in China, North Asia & Oceania, in all categories Solid growth in North America, led by a continued, winning momentum in High Protein Consistent progress in Europe with solid volume/mix 2025 guidance confirmed, in line with mid-term ambition: LFL sales growth expected between +3% and +5%, with recurring operating income growing faster than sales € million except % Q1 2024 Q1 2025 Reported change LFL sales growth Volume/mix growth BY GEOGRAPHICAL ZONE Europe 2,336 2,389 +2.3% +2.0% +1.9% North America 1,737 1,633 -5.9% +3.7% +0.9% China, North Asia & Oceania 840 936 +11.5% +9.9% +10.4% Latin America 727 715 -1.6% +9.0% -2.1% Rest of the World 1,150 1,170 +1.7% +3.3% -1.0% BY CATEGORY EDP 3,474 3,381 -2.7% +3.7% +1.5% Specialized Nutrition 2,183 2,306 +5.7% +5.3% +3.1% Waters 1,132 1,156 +2.2% +4.1% +1.0% TOTAL 6,789 6,844 +0.8% +4.3% +1.9% 1 Antoine de Saint-Affrique: CEO statement With a +4.3% like-for-like sales growth in Q1, we have delivered a strong start to the year, across all categories, demonstrating the strength of our execution and the relevance of our health-focused portfolio. In the current uncertain environment, our science-based innovations, our consumer and patient-centric approach, and our increasingly diversified channel footprint further contribute to the resilience of our business.
